Lugobe H, Kayondo M, Mceniery C, Catov J, Wilkinson I, Wylie B
AJOG Glob Rep. 2023; 3(1):100163.
PMID: 36860930
PMC: 9969249.
DOI: 10.1016/j.xagr.2023.100163.
Kanninen T, Jung E, Gallo D, Diaz-Primera R, Romero R, Gotsch F
J Matern Fetal Neonatal Med. 2022; 36(1):2153034.
PMID: 36521862
PMC: 10291739.
DOI: 10.1080/14767058.2022.2153034.
Jacobsen D, Fjeldstad H, Johnsen G, Fosheim I, Moe K, Alnaes-Katjavivi P
Front Immunol. 2021; 12:791606.
PMID: 34970270
PMC: 8712939.
DOI: 10.3389/fimmu.2021.791606.
Sun X, Zhang S, Song H
Lipids Health Dis. 2020; 19(1):180.
PMID: 32758232
PMC: 7409636.
DOI: 10.1186/s12944-020-01357-w.
Khaliq O, Konoshita T, Moodley J, Naicker T
Curr Hypertens Rep. 2018; 20(9):80.
PMID: 29992361
DOI: 10.1007/s11906-018-0878-7.
The profiles of soluble adhesion molecules in the "great obstetrical syndromes".
Docheva N, Romero R, Chaemsaithong P, Tarca A, Bhatti G, Pacora P
J Matern Fetal Neonatal Med. 2018; 32(13):2113-2136.
PMID: 29320948
PMC: 6070437.
DOI: 10.1080/14767058.2018.1427058.
Omega-3 Long-Chain Polyunsaturated Fatty Acids and Preeclampsia: Trials Say "No," but Is It the Final Word?.
Burchakov D, Kuznetsova I, Uspenskaya Y
Nutrients. 2017; 9(12).
PMID: 29244779
PMC: 5748814.
DOI: 10.3390/nu9121364.
Estimation of Serum Uric Acid as an Indicator of Severity of Preeclampsia and Perinatal Outcome.
Nair A, Savitha C
J Obstet Gynaecol India. 2017; 67(2):109-118.
PMID: 28405118
PMC: 5371522.
DOI: 10.1007/s13224-016-0933-8.
Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia.
Shah D, Khalil R
Biochem Pharmacol. 2015; 95(4):211-26.
PMID: 25916268
PMC: 4449835.
DOI: 10.1016/j.bcp.2015.04.012.
The Impact of Preeclampsia on Gene Expression at the Maternal-Fetal Interface.
Winn V, Gormley M, Fisher S
Pregnancy Hypertens. 2011; 1(1):100-8.
PMID: 21743843
PMC: 3129988.
DOI: 10.1016/j.preghy.2010.12.001.
Autoantibody-mediated IL-6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsia.
Zhou C, Irani R, Dai Y, Blackwell S, Hicks M, Ramin S
J Immunol. 2011; 186(10):6024-34.
PMID: 21482739
PMC: 3269191.
DOI: 10.4049/jimmunol.1004026.
Endothelin-dependent vasoconstriction in human uterine artery: application to preeclampsia.
Dechanet C, Fort A, Barbero-Camps E, Dechaud H, Richard S, Virsolvy A
PLoS One. 2011; 6(1):e16540.
PMID: 21298073
PMC: 3027698.
DOI: 10.1371/journal.pone.0016540.
Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia.
Reslan O, Khalil R
Cardiovasc Hematol Agents Med Chem. 2010; 8(4):204-26.
PMID: 20923405
PMC: 2951603.
DOI: 10.2174/187152510792481234.
Microbial invasion of the amniotic cavity in preeclampsia as assessed by cultivation and sequence-based methods.
DiGiulio D, Gervasi M, Romero R, Mazaki-Tovi S, Vaisbuch E, Kusanovic J
J Perinat Med. 2010; 38(5):503-13.
PMID: 20482470
PMC: 3325506.
DOI: 10.1515/jpm.2010.078.
Circulating and Vascular Bioactive Factors during Hypertension in Pregnancy.
Tanbe A, Khalil R
Curr Bioact Compd. 2010; 6(1):60-75.
PMID: 20419111
PMC: 2856945.
DOI: 10.2174/157340710790711737.
Factors associated with persistent hypertension after puerperium among women with pre-eclampsia/eclampsia in Mulago hospital, Uganda.
Ndayambagye E, Nakalembe M, Kaye D
BMC Pregnancy Childbirth. 2010; 10:12.
PMID: 20222993
PMC: 2848130.
DOI: 10.1186/1471-2393-10-12.
Risk factors and mediators of the vascular dysfunction associated with hypertension in pregnancy.
Sheppard S, Khalil R
Cardiovasc Hematol Disord Drug Targets. 2010; 10(1):33-52.
PMID: 20041838
PMC: 2855626.
DOI: 10.2174/187152910790780096.
Leukocytes of pregnant women with small-for-gestational age neonates have a different phenotypic and metabolic activity from those of women with preeclampsia.
Ogge G, Romero R, Chaiworapongsa T, Gervasi M, Pacora P, Erez O
J Matern Fetal Neonatal Med. 2009; 23(6):476-87.
PMID: 19916874
PMC: 3426366.
DOI: 10.3109/14767050903216033.
A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia.
Kusanovic J, Romero R, Chaiworapongsa T, Erez O, Mittal P, Vaisbuch E
J Matern Fetal Neonatal Med. 2009; 22(11):1021-38.
PMID: 19900040
PMC: 3427777.
DOI: 10.3109/14767050902994754.
Could alterations in maternal plasma visfatin concentration participate in the phenotype definition of preeclampsia and SGA?.
Mazaki-Tovi S, Romero R, Kwon Kim S, Vaisbuch E, Kusanovic J, Erez O
J Matern Fetal Neonatal Med. 2009; 23(8):857-68.
PMID: 19900033
PMC: 3554253.
DOI: 10.3109/14767050903301017.